
Silakan coba pencarian lain
YTD | 3Bln | 1T | 3Thn | 5T | 10T | |
---|---|---|---|---|---|---|
Pertumbuhan 1000 | 990 | 1052 | 1210 | 2163 | 2980 | 3090 |
Imbal Hasil Dana | -0.98% | 5.21% | 20.97% | 29.33% | 24.41% | 11.94% |
Posisi di kategori | 15 | 71 | 24 | 8 | 14 | 15 |
% di kategori | 13 | 75 | 22 | 9 | 23 | 72 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Fund Direct Div | 756,39B | 11,48 | 18,61 | 13,33 | ||
SBI Magnum Balanced Fund Direct Gro | 756,39B | 11,48 | 18,61 | 13,42 | ||
SBI Magnum Balanced Fund Regular Gr | 756,39B | 11,12 | 17,81 | 12,48 | ||
SBI Magnum Balanced Reg Div Payout | 756,39B | 11,12 | 17,81 | 12,40 | ||
SBI Bluechip Fund Regular Growth | 522,51B | 7,21 | 19,22 | 12,71 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 83,52B | -1,55 | 25,78 | 14,50 | ||
Reliance Pharma Dividend Payout | 83,52B | -2,36 | 25,12 | 15,45 | ||
Reliance Pharma Fund - Growth | 83,52B | -1,55 | 25,78 | 14,50 | ||
Reliance Pharma Direct Bonus | 83,52B | -1,11 | 26,91 | 15,53 | ||
Reliance Pharma Direct Growth | 83,52B | -1,11 | 26,91 | 15,53 |
Nama | ISIN | Bobot % | Terakhir | Perubahan % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12,73 | 1.672,00 | +0,57% | |
Divi's Labs | INE361B01024 | 7,39 | 6.835,00 | -0,14% | |
Max Healthcare Institute | INE027H01010 | 6,40 | 1.219,20 | -2,59% | |
Lonza Group AG | US54338V1017 | 4,81 | 70,72 | -0,66% | |
Cipla | INE059A01026 | 4,77 | 1.485,00 | +0,49% |
Jenis | Harian | Mingguan | Bulanan |
---|---|---|---|
Moving Average | Beli | Beli | Beli |
Indikator Teknikal | Sangat Beli | Sangat Beli | Sangat Beli |
Rangkuman | Sangat Beli | Sangat Beli | Sangat Beli |
Anda yakin ingin memblokir %USER_NAME%?
Jika ya, Anda dan %USER_NAME% tidak akan dapat melihat posting satu sama lain di Investing.com.
%USER_NAME% berhasil dimasukkan ke Daftar Blokir Anda
Karena Anda baru saja membatalkan blokir pengguna ini, Anda harus menunggu 48 jam sebelum kembali memblokir.
Menurut saya, komentar ini:
Terima Kasih!
Laporan Anda telah terkirim untuk ditinjau oleh moderator kami